Results 101 to 110 of about 1,239 (187)

Using ChEMBL to Complement Schistosome Drug Discovery. [PDF]

Pharmaceutics, 2023
Padalino G, Coghlan A, Pagliuca G, Forde-Thomas JE, Berriman M, Hoffmann KF.   +5 more
europepmc   +1 more source

Extensive parasite transmission and variation in a functional receptor associated with drug resistance in endemic <i>Schistosoma mansoni</i>. [PDF]

Sci Adv
Berger DJ, Park SK, Crellen T, Vianney TJ, Kabatereine NB, Cotton JA, Sanya R, Elliott A, Tukahebwa EM, Adriko M, Standley CJ, Gouvras A, Kinung'hi S, Rabone M, Emery A, Lamberton PHL, Webster BL, Allan F, Buddenborg S, Berriman M, Marchant JS, Doyle SR, Webster JP.   +22 more
europepmc   +1 more source

Considering ivermectin for treatment of schistosomiasis. [PDF]

Parasitol Res
Golenser J, Birman I, Gold D.
europepmc   +1 more source

Computer-Assisted Discovery of Salvia fruticosa Compounds With Schistosomicidal Activity. [PDF]

Bioinform Biol Insights
Shoko R, Mandivenga F.
europepmc   +1 more source

CRISPR/Cas genome editing, functional genomics, and diagnostics for parasitic helminths. [PDF]

Int J Parasitol
Koike A, Brindley PJ.
europepmc   +1 more source

Metabolomic profile and bioactivity of fungal endophytes isolated from Crinum macowanii. [PDF]

BMC Complement Med Ther
Ogofure AG, Sebola T, Green E.
europepmc   +1 more source

Disulfiram and Its Derivatives: An Immortal Phoenix of Drug Repurposing. [PDF]

Pharmaceuticals (Basel)
Omran Z, Abdullah O.
europepmc   +1 more source

Schistosome Transgenesis: The Long Road to Success. [PDF]

Biology (Basel)
Kalinna BH, Ross AG, Walduck AK.
europepmc   +1 more source

A comprehensive exploration of schistosomiasis: Global impact, molecular characterization, drug discovery, artificial intelligence and future prospects. [PDF]

Heliyon
Ekloh W, Asafu-Adjaye A, Tawiah-Mensah CNL, Ayivi-Tosuh SM, Quartey NK, Aiduenu AF, Gayi BK, Koudonu JAM, Basing LA, Yamoah JAA, Dofuor AK, Osei JHN.   +11 more
europepmc   +1 more source

Praziquantel and factor H recruitment differentially affect the susceptibility of Schistosoma mansoni to complement-mediated damage. [PDF]

Front Immunol
van Beek AE, Jeanguenat H, Häberli C, Pouw RB, Lamers C, Pál G, Gál P, Schmidt CQ, Ricklin D, Keiser J.   +9 more
europepmc   +1 more source